VTRS Latest Press Releases

-- October 16, 2026 --

Viatris Receives U.S. FDA Approval for RYZUMVI for the Treatment of Presbyopia PRNewswire 4:06 PM

-- October 12, 2026 --

Pacira BioSciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Pacira BioSciences, Inc. - PCRX Business Wire 12:43 PM

-- October 8, 2026 --

Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies PRNewswire 7:45 AM

-- October 5, 2026 --

Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026 PRNewswire 6:59 AM

-- September 29, 2026 --

Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year PRNewswire 2:00 PM

-- September 16, 2026 --

Viatris Announces Approval of WAKIX (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome PRNewswire 6:59 AM

-- August 6, 2026 --

Viatris Reports Second-Quarter 2026 Financial Results PRNewswire 6:59 AM

-- August 4, 2026 --

Viatris Announces Quarterly Dividend PRNewswire 6:59 AM

-- July 29, 2026 --

Viatris Receives U.S. FDA Approval for Gwyn Lo , a Once-Weekly Contraceptive Patch PRNewswire 6:59 AM

-- July 1, 2026 --

Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026 PRNewswire 6:59 AM

-- June 29, 2026 --

Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy PRNewswire 6:59 AM

-- June 16, 2026 --

Viatris Recognized as One of the 2026 Best Workplaces in Canada PRNewswire 6:59 AM

Market Data Delayed 15 Minutes